CAR T-cell therapy

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  

CAR T-cell therapy
Jan 15, 2025, 17:14 | Insight
Elias Orouji: A comprehensive review of the application of CAR-T cell therapy in colorectal cancer
Elias Orouji, Epigenomics Lead at Princess Margaret Genomics Centre, shared a post X about a…
Jan 14, 2025, 19:05 | Science
Shaida Ouladan: Chimeric Antigen Receptor-T Cells in Colorectal Cancer
Shaida Ouladan, a Molecular Pathology Scientist, shared a recent article on LinkedIn: "I’m thrilled to…
Jan 14, 2025, 15:01 | Career
OncoInfluencers to Follow on Social Media: Nico Gagelmann
We’re excited to feature Nico Gagelmann, a distinguished physician and scientist, as our next oncoinfluencer.…
Jan 13, 2025, 15:28 | Insight
CAR-T cell therapy for breast cancer: Current status and future perspective
A recent paper by Giuseppe Buono, Medical Doctor at IRCCS National Cancer Institute "Fondazione G.…
Jan 10, 2025, 06:42 | Science
Samer Al Hadidi: Safety and efficacy of CAR-T cell therapy in patients with autoimmune diseases
Samer Al Hadidi, Assistant Professor at UAMS Myeloma Center, posted on X about recent paper…
Jan 8, 2025, 12:34 | Insight
Hung Trinh: Researchers have re-engineered immune cells that penetrate and kill solid tumors
Hung Trinh, Senior Director of Business Development at OBiO Tech, shared a post on LinkedIn:…
Jan 6, 2025, 14:52 | Blog
E.Senthil Kumar: From Shadows to Solutions - The Revolution Against Cancer
E.Senthil Kumar, Medical Oncologist at Red Hills, Chennai, shared a post on X: "From Shadows…
Dec 29, 2024, 16:39 | Science
Myeloma Paper of the Day, December 29th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: BCMA-directed CAR T-cell therapy…
Dec 28, 2024, 14:09 | Science
The new NCCN guidelines for immunotherapy-related toxicities
Elvina Almuradova, Associate Professor and Medical Oncologist Ambassador at European School of Oncology, shared a…
Dec 27, 2024, 17:35 | Blog
Rahul Gosain: CLL Highlights with John Allan
Rahul Gosain, Director of Regional Infusion Services and Medical Director at Wilmot Cancer Institute, shared a…
Dec 23, 2024, 21:16 | Insight
Hung Trinh: CAR-T cell therapy for the treatment of adult high-grade gliomas
Hung Trinh, Senior Director of Business Development at OBiO Tech, shared a post on LinkedIn:…
Dec 16, 2024, 13:20 | Blog,Science
Predicting the effectiveness of CAR T-cell therapy in children with leukemia (B-ALL) - The Princess Máxima Center for Pediatric Oncology
The Princess Máxima Center for Pediatric Oncology posted on LinkedIn: "Two new studies start thanks…
Dec 15, 2024, 18:38 | Science
Ahmed Kotb: Infection risk in CAR T-cell therapy
Ahmed Kotb, Hematologist and Bone marrow transplanter at King Faisal Specialist Hospital International Holding Company…
Dec 12, 2024, 16:30 | Insight
Miguel Bronchud about long term toxicities of CAR-T
Miguel Bronchud, Co-Founder and Advisory Board at Regenerative Medicine Solutions, shared a post on LinkedIn:…
Nov 21, 2024, 09:55 | Blog
New Hope for Mantle Cell Lymphoma Patients - The Babak Lab
The Babak Lab shared a post on LinkedIn: “FDA Approval Alert: New Hope for Mantle…
Nov 17, 2024, 18:26 | Opinion
Patrick Hwu: How can we enhance CAR-T cell activity against solid cancers?
Patrick Hwu, President and CEO of Moffitt Cancer Center, shared a post on X: "How can we enhance…
Nov 16, 2024, 16:02 | Insight
Shahrin Ahmed: CAR-T cells as a new treatment for Glioblastoma
Shahrin Ahmed, Medical specialist in oncology at the Canadian Cancer Society, shared a post on…
Nov 16, 2024, 15:48 | Blog
Could CAR T-cell therapy show promise against deadly childhood brain cancer - Cancer Research Institute
Cancer Research Institute (CRI) shared a post on LinkedIn: "Could CAR T-cell therapy show promise…
Nov 10, 2024, 12:56 | Blog
Interius BioTherapeutics Doses First Patient with in vivo CAR Gene Therapy for B-cell Malignancies
INT2104 is a novel in vivo chimeric antigen receptor (CAR) gene therapy designed to generate…
Nov 10, 2024, 04:17 | Blog
M. Bilal Abid: Reporting data on the efficacy and safety of bispecific CAR T-cell therapy in hematological malignancies
M. Bilal Abid, Research Fellow in Cancer Therapeutics at MD Anderson Cancer Center, shared on…
Nov 9, 2024, 12:04 | Insight
Celebrating 40 Years of TCR Discovery: A Gathering of Giants in T Cell Immunology
This year marks the 40th anniversary of the discovery of the T cell receptor (TCR),…
Nov 8, 2024, 14:11 | Blog
Atrium Health Opens State-of-the-Art Outpatient Transplant and Cellular Therapy Unit
Atrium Health recently celebrated the opening of the Levine Cancer Institute’s Outpatient Transplant and Cellular…
Nov 7, 2024, 13:07 | Blog
Francisco Conesa Buendía: Advancing CAR-T Cell Therapy for Solid Tumors
Francisco Conesa Buendía, Assistant of Cell and Gene Therapies Manufacturing at Memorial Sloan Kettering Cancer…
Nov 6, 2024, 12:01 | Insight
John Gordon: Dual “ON/OFF”-switch CARs offer a safer CAR T cell therapy
John Gordon, Vice president of Scientific Affairs at Celentyx Ltd, shared a post on LinkedIn: “Dual ‘ON/OFF’-switch CARs…
Nov 4, 2024, 15:55 | Insight
Yan Leyfman: An innovative approach to promote CAR T cell longevity and boost therapeutic efficacy
Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared a post on LinkedIn by Francisco…
Oct 30, 2024, 13:33 | Blog
Francisco Conesa Buendía: How CRISPR is shaping the future of CAR T-cell therapy
Francisco Conesa Buendía, Cell and Gene Therapies Manufacturing Assistant at Memorial Sloan Kettering Cancer Center,…
Oct 14, 2024, 18:16 | Blog
Yan Leyfman: An innovative approach to challenges of CAR T cell therapy
Yan Leyfman shared a post by Christine H., Director, Gilead Sciences, on LinkedIn, adding: "An innovative approach…
Oct 11, 2024, 15:13 | Insight
Aggressive Lymphoma after CD19 CAR T-Cell Therapy suggested by Vivek Subbiah
Vivek Subbiah shared a post on X: "Aggressive Lymphoma after CD19 CAR T-Cell Therapy clonal hematopoiesis…
Oct 7, 2024, 11:25 | Blog
Jeff Sharman: Reflecting on the incredible progress made in lymphoma research
Jeff Sharman, Medical Director for Hematology Research at US Oncology, shared a post on LinkedIn,…
Oct 2, 2024, 15:25 | Blog
Can CAR T cell therapy be used to fight prostate cancer? - Cancer Research Institute
Cancer Research Institute shared a report by Charlie Schmidt on LinkedIn: "Can CAR T cell…
Sep 26, 2024, 17:47 | Insight
Charles Gaulin: Our initiative on enhancing advance care planning has received an ASCO Conquer Cancer Merit Award
Charles Gaulin shared a post on LinkedIn: "Excited to announce that our quality improvement initiative…
Sep 24, 2024, 12:50 | Dialogues
60 +1 Questions About Acute Lymphoblastic Leukemia in Children with Scott Howard
Professor Scott Howard is the Deputy Director at Yeolyan Hematology and Oncology Centerand the CEO…
Sep 14, 2024, 17:46 | Insight
Kai Rejeski: Second Primary Malignancies following CAR T-cell therapy
Kai Rejeski shared a post on X about a recent paper by Tobias Tix et…
Sep 5, 2024, 15:47 | Blog
Many Minds. One Focus - The Brain Cancer Centre
The Brain Cancer Centre made the following post on LinkedIn: "Awesome to see our Research Rockstar…
Sep 5, 2024, 05:09 | Blog
Joshua Brody: Excited for the CME event on CAR T-cell therapy for lymphoma and CLL at SOHO2024
Joshua Brody shared on LinkedIn: "Excited for the Amps-to-go-up-to-11 at tomorrow's CME event on CAR…
Aug 27, 2024, 21:34 | Insight
Shahrin Ahmed: Addressing weaknesses in invasive brain cancer by utilizing ROBO1 CAR T cells
Shahrin Ahmed, Medical Specialist at the Canadian Cancer Society, shared a post on X: “Exploiting…
Aug 22, 2024, 13:58 | Blog
Rutgers Cancer Institute has treated its 200th patient with CAR T-cell therapy
Rutgers Cancer Institute shared on X:  “Rutgers Cancer Institute, the state’s only National Cancer Institute…
Aug 17, 2024, 19:47 | Blog
Marc Braunstein: Updates on CAR T-cell therapy in myeloma
Marc Braunstein, Associate Professor, Department of Medicine at NYU Grossman Long Island School of Medicine, shared…
Aug 16, 2024, 14:18 | Blog
Exploring CAR T-cell therapy and second cancers with Stephanie Goff on NCI's Cancer Currents blog - NCI Center for Cancer Research
NCI Center for Cancer Research shared on LinkedIn: "Cancer Currents: In this Q and A,…
Aug 14, 2024, 14:12 | Insight
ESHIMMUNE2024 starts in exactly one month
The ESH 3rd Translational Research Conference on Immune and Cellular Therapies: Focus on Advanced Gene-Engineered…
Aug 11, 2024, 11:41 | Insight
Hung Trinh: A rapid establishment for CAR T Cell Therapy Treatment Center Locator
Hung Trinh, Director of Process Development and MFG Science and Technology at Vyriad, posted on LinkedIn:…
Aug 10, 2024, 12:57 | Insight
MD Anderson Research Highlights
Featuring cell biology insights, new targets to prevent dysphagia, improved treatments for advanced cancers and…
Aug 4, 2024, 03:36 | Insight
Rahul Banerjee: Fascinating paper about time of day affecting CAR T-cell function
Rahul Banerjee, EASE (ECE Advocacy for Student Engagement) Director of Communications at Duke University Pratt…
Aug 3, 2024, 09:33 | Blog
Nonrelapse mortality after CAR T cell therapy by Dr. Kai Rejeski - IACH
The International Academy for Clinical Hematology shared a post on X: "Hear the latest at The…
Aug 1, 2024, 14:48 | Insight
Angela Mastronuzzi: The current landscape of CAR T-cell therapy for CNS tumors
Angela Mastronuzzi shared a post on LinkedIn about a recent paper titled "Chimeric antigen receptor…
Jul 30, 2024, 13:25 | Insight
David Fajgenbaum: Untold story of a drug initially approved for Castleman Disease that saved a young girl's life
David Fajgenbaum shared on X: "Did you know that a repurposed drug saved the most…
Jul 23, 2024, 07:41 | Blog
Tom Lynch: Fred Hutchinson Cancer Center expands immunotherapy offerings
Mazyar Shadman, Associate Professor of Medical Oncology at Fred Hutch Cancer Centre, shared a post…
Jul 21, 2024, 16:40 | Insight
Hung Trinh: FDA breakthrough designation for trial of cell-based therapy for high-risk lymphoma
Hung Trinh, Director of Process Development and MFG Science and Technology at Vyriad, posted on LinkedIn:…
Jul 18, 2024, 22:39 | Blog
Angela Mastronuzzi: GD2-Targeting therapy for GD2+ Medulloblastoma
Angela Mastronuzzi shared a post on LinkedIn: ''GD2-Targeting CAR T-cell Therapy for Patients with GD2+…
Jul 17, 2024, 14:06 | Opinion
ACGT awarded a $500,000 grant to Crystal Mackall to develop a CAR T-cell therapy
Alliance for Cancer Gene Therapy shared on X: "ACGT has awarded a $500,000 grant to…
Jul 12, 2024, 19:08 | Insight
Interesting study - A meta-analysis of nonrelapse mortality after CAR T cell therapy
Vivek Subbiah shared on X: "Interesting study published in NatureMedicine: A systematic review and meta-analysis…
Jul 9, 2024, 06:46 | Blog
David Cordas dos Santos: Nonrelapse mortality after CAR-T cell treatment
David Cordas dos Santos, PostDoc at Dana-Farber Cancer Institute, made the following post on X:…
Jul 8, 2024, 17:31 | Insight
Kai Rejeski: Underestimated aspect of CAR T-cell therapy: non-relapse mortality
Kai Rejeski, Visiting investigator at Memorial Sloan Kettering Cancer Center, shared on X: “Hot off…
Jul 7, 2024, 14:59 | Insight
Advancements in Oncology and Cancer Understanding - The Babak Lab
The Babak Lab made the following post on LinkedIn: "Weekly Digest Advancements in Oncology and Cancer…
Jul 6, 2024, 14:42 | Blog
Craig Bunnell has earned distinction as the inaugural Morse Family Chief Medical Officer - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute posted on LinkedIn: "After more than 15 years as a member of…
Jul 5, 2024, 14:45 | Insight
Maria Babak: Must read on CAR T-Cell Therapy
Maria Babak shared a post by The Babak Lab on LinkedIn: “This is a must-read…
Jun 24, 2024, 22:06 | Blog
Nausheen Ahmed: Approvals, toxicity and access updates on CART
Nausheen Ahmed, Medical Director of BMT Survivorship Program at The University of Kansas, shared a…
Jun 20, 2024, 07:48 | Blog
Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy
Vivek Subbiah shared a post on X: "Risk of Second Tumors and T-Cell Lymphoma after CAR…
Jun 18, 2024, 14:43 | Immune Oncology
CAR T Cell Therapy for Cancer Treatment
Introduction Chimeric antigen receptor - CAR T Cell therapy represents a groundbreaking approach in cancer…
Jun 14, 2024, 02:22 | Opinion
Harshal Chorya: Dr. Sam Yamshon captivating keynote on B-Cell Lymphomas
Harshal Chorya, HealthCare Professional at Baroda Medical College, shared a post on X: "Breakthrough Alert!…
Jun 13, 2024, 13:16 | Insight
Fabiana Perna: Our paper on novel toxicities of CAR T cell therapy
Fabiana Perna, Associate Member of Moffitt Cancer Center, shared on X: "Excited to share our paper…
May 31, 2024, 14:27 | Immune Oncology
How Does Immunotherapy Work
What is immunotherapy? Immunotherapy is a type of cancer treatment that uses the power of…
May 30, 2024, 16:14 | Blog
Alexander González: The challenges of CARNK existing in the process from lab production to tumor infiltration
Alexander González, Internal Clinician at 3cert Limited, shared on LinkedIn: “The challenges of CARNK existing…
May 28, 2024, 14:06 | Insight
Myeloma Paper of the Day, May 28th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Retrospective Memorial Sloan Kettering study suggests…
May 22, 2024, 13:51 | Blog
Gaurav Narula: Great two days brainstorming to help formulate the research questions for CAR T cell therapy
Gaurav Narula, Medical Oncologist at Postgraduate Institute of Medical Education and Research, Chandigarh, shared a…
May 21, 2024, 15:48 | Blog
Cancer Network - A panel of experts on multiple myeloma discuss the rationale for CAR T-cell therapy
Rahul Banerjee, Assistant Professor at UW Medicine, shared a post by Cancer Network, on X: "So much fun…
May 21, 2024, 15:16 | Blog
A panel of experts on multiple myeloma discuss the rationale for CAR T-cell therapy - Cancer Network
Cancer Network shared a post on X: "A panel of experts on multiple myeloma discuss…
May 16, 2024, 15:09 | Insight
Myeloma Paper of the Day, May 16th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: DESCAR-T registry of French patients…
May 15, 2024, 10:54 | Dialogues
Oncothon: Challenges And Successes In Pediatric Hematology and Oncology
Oncothon is a telethon spanning 24 hours, dedicated to gathering donations for childhood cancer research.…
May 8, 2024, 13:50 | Opinion
NCI Center for Cancer Research - Alka Dwivedi was honored in this year's list of TIME100 Most Influential in Health
NCI Center for Cancer Research shared a post on LinkedIn: "IN THE NEWS: If you haven't…
May 3, 2024, 23:43 | Blog
Tanja Obradovic: All eyes are on ADCs coming from China's biotech innovation engine and CAR-T cell therapy
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON plc., shared a post on…
May 1, 2024, 10:09 | Blog
Amanda Impellizzeri: Thank you for making the West Virginia Oncology Society Spring Conference a success
Amanda Impellizzeri, Executive Director at Louisiana Oncology Society, posted on LinkedIn: "Thank you to all the…
Apr 28, 2024, 23:40 | Blog
Susanna Greer: Boosting the CAR T party
Susanna Greer, Chief Scientific Officer at the V Foundation for Cancer Research, published the following…
Apr 20, 2024, 18:05 | Insight
Nicolas Hubacz: T Cell Vs Cancer Cell
Nicolas Hubacz, Research Products Business Development Manager at Magstim, shared a post on LinkedIn: "CAR…
Apr 20, 2024, 17:31 | Blog
The U.S. FDA recently approved two CAR T-cell therapies for earlier treatment of adults with multiple myeloma - The Leukemia and Lymphoma Society
The Leukemia and Lymphoma Society shared a post on LinkedIn: "PROGRESS! The U.S. FDA recently approved…
Apr 16, 2024, 01:52 | Insight,Opinion
Angela Mastronuzzi: We investigated whether CAR T-cells directed towards the disialoganglioside GD2 can represent a potentially more effective treatment with reduced long-term side effects
Apr 15, 2024, 16:17 | Blog
Selwyn M. Vickers: MSK hosted a screening of the documentary Living Drugs
Selwyn M. Vickers, President and CEO at Memorial Sloan Kettering Cancer Center shared on X:…
Apr 11, 2024, 12:10 | Blog
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma, by Sumanta K. Pal et al - Cancer Discovery
Cancer Discovery shared on X/Twitter: "Just published with the AACR24 Clinical Plenary presentation: CD70-Targeted Allogeneic CAR…
Apr 9, 2024, 13:09 | Insight
New allogeneic CAR T cell therapy for advanced kidney cancer and an oncolytic immunotherapy for organ transplant patients with skin cancer - MD Anderson Cancer Center
MD Anderson Cancer Center shared on LinkedIn: ''At the 2024 American Association for Cancer Research Annual…
Apr 8, 2024, 21:58 | Blog,Insight
Katherine Masih: Super interesting work on activation of CAR-negative T-cells and subsequent cytotoxic killing of leukemia
Katherine Masih, Medical Student at University of Miami Miller School of Medicine, shared on X/Twitter:…
Apr 8, 2024, 16:03 | Insight
Gaurav Narula: India’s first CAR-T cell therapy
Gaurav Narula, Professor Paediatric Oncology and Health Sciences at Tata Memorial Center, shared the following…
Mar 28, 2024, 00:14 | Blog
E. Anders Kolb: LLS’s Chief Medical Officer Gwen Nichols recently addressed what patients need to know about CAR-T and what questions remain in her interview with CURE Media Group
Mar 20, 2024, 16:53 | Insight
Vincent Rajkumar: ODAC votes 11-0 to recommend approval of Cilta-Cel in patients with relapsed/refractory multiple myeloma in earlier stages
Vincent Rajkumar, Editor in Chief of Blood Cancer Journal, shared on X/Twitter: "Breaking: ODAC votes…
Mar 13, 2024, 22:40 | Insight
Gaurav Narula: When none believed, our institutions at Tata Memorial Hospital, IIT Bombay did
Gaurav Narula, Professor Pediatric Oncology and Health Sciences at Tata Memorial Center, shared an X…
Feb 25, 2024, 15:47 | Insight
Patrick Hwu: Did you know that CAR T-cell therapy could effectively treat autoimmune diseases?
Patrick Hwu, President and CEO at Moffitt Cancer Center, shared on X: "Did you know…
Feb 21, 2024, 18:18 | Insight
Vivek Subbiah: As of December 31, 2023, the FDA had become aware of 22 cases of T-cell cancers that occurred after treatment with CAR-T products
Vivek Subbiah shared on LinkedIn: "Perspective article on 'Secondary Cancers after Chimeric Antigen Receptor T-Cell…
Jan 19, 2024, 18:16 | Blog
Satya Prakash Yadav: Is chemotherapy free treatment of leukemia possible?
Satya Prakash Yadav, Director of Paediatric Hemato-Oncology and Bone Marrow Transplant at Medical and Haemato-Oncology…
Jan 10, 2024, 12:30 | Insight
Hung Trinh: Researchers Develop a Potential “Universal” CAR T-Cell Therapy for Blood Cancers
Hung Trinh, Director of Process Development and MFG Science and Technology at Vyriad, posted on LinkedIn:…
Dec 27, 2023, 17:10 | Blog
Julie Vose: She is a trooper and now sporting new hair and wearing lipstick!
Julie Vose shared a post by Nebraska Medicine on X/Twitter: "What a courageous strong woman!…
Dec 21, 2023, 16:55 | Blog
Sam Yamshon: Absolute tour de force by our fellow extraordinaire Mohammad Alhomoud
Sam Yamshon, Hematologist/Oncologist at Weill Cornell Medicine, shared on X/Twitter: "Absolute tour de force by…
Dec 21, 2023, 10:30 | Blog
MSKCC experts presented research related to managing and reducing treatment-related toxicities at the ASH - Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center shared on LinkedIn: ''Memorial Sloan Kettering Cancer Center (MSK) experts,…
Dec 19, 2023, 16:41 | Insight
Maria Natalia Gandur Quiroga: Pioneering Equity in Cancer Treatment: A Model Worth Emulating
Maria Natalia Gandur Quiroga shared on LinkedIn: "Pioneering Equity in Cancer Treatment: A Model Worth…
Dec 8, 2023, 12:47 | Insight
Talha Badar: A few selected ALL abstracts to watch for at ASH23
Talha Badar, Assistant Professor of Oncology at Mayo Clinic Comprehensive Cancer Center, posted on X/Twitter:…
Dec 1, 2023, 22:33 | Blog
Jose Vicente Cardona: Here are nine recent developments in the fight against cancer
Jose Vicente Cardona, Group Director Oncology, Global Medical Affairs at Roche, made the following post…
Nov 6, 2023, 17:36 | Blog
Manni Mohyuddin: Every day in my clinic, there is selection bias in favor of an increase in PFS for CAR T-cell therapy
Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute at the University of Utah, shared…
Oct 20, 2023, 19:47 | Blog
Nicholas Vitanza: Thank you, Society of Research Administrators International
Nicholas Vitanza, Pediatric neuro-oncologist at Seattle Children's Hospital, shared on X/Twitter: "Thank you, Society of…
Oct 15, 2023, 18:02 | Insight
India's First Approved CAR-T Cell Therapy - No Longer Sci-Fi, Now a Reality! - ImmunoACT
ImmunoACT shared on Twitter: "A New Hope: India's First Approved CAR-T Cell Therapy - No…
Oct 12, 2023, 18:13 | Blog
María Natalia Gandur Quiroga: Fantastic review! A pleasure to read: Understanding the Cancer-Immunity Cycle.
Quoting María Natalia Gandur Quiroga on X/Twitter: "Fantastic review! A pleasure to read: Understanding the Cancer-Immunity…
Oct 10, 2023, 21:21 | Opinion
Manni Mohyuddin: Some days you see unjust racial disparities-such as Medicaid pts not covered for CAR-T.
Manni Mohyuddin, Assistant Professor in the Division of Hematology/Bone Marrow Transplant at the University of…
Sep 21, 2023, 18:12 | Insight
Fiona Hamilton Marshall: These are hopeful findings for patients with relapsed/refractory diffuse large B-cell lymphomawho may not have a durable response to existing therapies.
12
All: 102 Posts: 1 - 100
Special Coverage